OBJECTIVES: To determine the impact of chronic rhinosinusitis (CRS) on the physical and mental health and health-resource utilization of Canadians. STUDY DESIGN: Cross-sectional. METHODS: Data from the detailed health portion of cycle 3 (1998-1999) of the National Population Health Survey (NPHS), which involved 17,000 Canadians, were used to evaluate Canadians with self-reported CRS. RESULTS: NPHS data confirmed lower mental and physical health, with CRS sufferers being almost three times more likely to report their health as poor (4.6% vs. 1.7%). Health Utility Index data identified a significant decline in the mental health of patients with CRS, which was associated with more depression (8.4% vs. 4.1%), more antidepressant use (9.1% vs. 4.6%), and more visits to mental-health professionals (11.8% vs. 7.0%). CONCLUSIONS: CRS significantly affects both physical and mental health. The mental impact of CRS remains largely unrecognized and should be of greater focus during patient care and in further research.
OBJECTIVES: To determine the impact of chronic rhinosinusitis (CRS) on the physical and mental health and health-resource utilization of Canadians. STUDY DESIGN: Cross-sectional. METHODS: Data from the detailed health portion of cycle 3 (1998-1999) of the National Population Health Survey (NPHS), which involved 17,000 Canadians, were used to evaluate Canadians with self-reported CRS. RESULTS: NPHS data confirmed lower mental and physical health, with CRS sufferers being almost three times more likely to report their health as poor (4.6% vs. 1.7%). Health Utility Index data identified a significant decline in the mental health of patients with CRS, which was associated with more depression (8.4% vs. 4.1%), more antidepressant use (9.1% vs. 4.6%), and more visits to mental-health professionals (11.8% vs. 7.0%). CONCLUSIONS:CRS significantly affects both physical and mental health. The mental impact of CRS remains largely unrecognized and should be of greater focus during patient care and in further research.
Authors: B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann Journal: HNO Date: 2012-02 Impact factor: 1.284
Authors: Martin Desrosiers; Gerald A Evans; Paul K Keith; Erin D Wright; Alan Kaplan; Jacques Bouchard; Anthony Ciavarella; Patrick W Doyle; Amin R Javer; Eric S Leith; Atreyi Mukherji; R Robert Schellenberg; Peter Small; Ian J Witterick Journal: Allergy Asthma Clin Immunol Date: 2011-02-10 Impact factor: 3.406
Authors: Agnes S Sundaresan; Annemarie G Hirsch; Margaret Storm; Bruce K Tan; Thomas L Kennedy; J Scott Greene; Robert C Kern; Brian S Schwartz Journal: Int Forum Allergy Rhinol Date: 2015-06-16 Impact factor: 3.858
Authors: A G Hirsch; X S Yan; A S Sundaresan; B K Tan; R P Schleimer; R C Kern; T L Kennedy; J S Greene; B S Schwartz Journal: Allergy Date: 2015-09-25 Impact factor: 13.146
Authors: Brett J Green; Donald H Beezhold; Zane Gallinger; Carly S Barron; Rochelle Melvin; Toni A Bledsoe; Michael L Kashon; Gordon L Sussman Journal: Allergy Asthma Clin Immunol Date: 2014-03-25 Impact factor: 3.406